Table 1 |
||
|
Listing of ICD-8 and ICD-10 codes used to ascertain key diagnoses |
||
| Diagnosis |
ICD-8 |
ICD-10 |
|
|
||
| Invasive breast carcinomaa |
174.00 to 174.02; 174.08; 174.09; |
C50.0 to C50.6; C50.8; C50.9 |
| Congestive heart failure |
427.09; 427.10; 427.11; 427.19; 428.99; 782.49 |
I50; I11.0; I13.0; I13.2 |
| Atrial fibrillation/flutterb |
427.93; 427.94 |
I48 |
| Myocardial infarction |
410 |
I21; I22; I23 |
| Peripheral vascular disease |
440; 441; 442; 443; 444; 445 |
I70; I71; I72; I73; I74; I77 |
| Cerebrovascular disease |
430 to 438 |
I60 to I69; G45; G46 |
| Chronic pulmonary disease |
490 to 493; 515 to 518 |
J40 to J47; J60 to J67; J68.4; J70.1; J70.3; J84.1; J92.0; J96.1; J98.2; J98.3 |
| Mild liver disease |
571; 573.01; 573.04 |
B18; K70.0 to K70.3; K70.9; K71; K73; K74; K76.0 |
| Moderate to severe liver disease |
070.00; 070.02; 070.04; 070.06; 070.08; 573.00; 456.00 to 456.09 |
B15.0; B16.0; B16.2; B19.0; K70.4; K72; K76.6; I85 |
| Diabetes type 1 |
249.00; 249.06; 249.07; 249.09 |
E10.0, E10.1; E10.9 |
| Diabetes type 2 |
250.00; 250.06; 250.07; 250.09 |
E11.0; E11.1; E11.9 |
| Moderate to severe renal disease |
403; 404; 580 to 583; 584; 590.09; 593.19; 753.10 to 753.19; 792 |
I12; I13; N00 to N05; N07; N11; N14; N17 to N19; Q61 |
| Diabetes with end organ damage (types 1 and 2) |
249.01 to 249.05; 249.08; 250.01 to 250.05; 250.08 |
E10.2 to E10.8; E11.2 to E11.8 |
| Solid tumor |
140 to 194 |
C00 to C75 |
| Lymphoma |
200 to 203; 275.59 |
C81 to C85; C88; C90; C96 |
|
|
||
|
aThe ICD codes for invasive breast carcinoma do not capture in situ tumors (for example, intraductal carcinoma); bICD-8 contained separate codes for atrial fibrillation (427.93) and flutter (427.94). These two diagnoses were combined into a single code in ICD-10 (I48). ICD, International Classification of Disease. |
||
|
Ahern et al. Breast Cancer Research 2008 10:R102 doi:10.1186/bcr2205 |
||
